Chugai Pharmaceutical Co., Ltd

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-07-16 EDT			5-day change	1st Jan Change
6,064 ^JPY	-3.50%		-2.08%	+13.52%

07-02	Financials lift Japanese shares on rate-hike speculation	RE
06-24	Japan's Nikkei ends choppy session on stronger note	RE

Chugai Pharmaceutical Co. Ltd. Provides Dividend Guidance for the First Half of 2016

January 28, 2016 at 11:30 am

Chugai Pharmaceutical Co. Ltd. provided dividend guidance for the first half and full year 2016. For the first half, the company forecasts a dividend of ¥26.00 per share.

Latest news about Chugai Pharmaceutical Co., Ltd

Financials lift Japanese shares on rate-hike speculation	07-01	RE
Japan's Nikkei ends choppy session on stronger note	06-24	RE
Japan's Nikkei squeezes out gains in choppy session	06-23	RE
Japan's Nikkei rises on US stocks, heavyweight chip shares	06-10	RE
Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook	05-22	RE
Japan's Nikkei drifts sideways as more earnings, US CPI awaited	05-13	RE
Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation	05-01	MT
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	04-25	MT
Chugai Pharmaceutical's Profit Slightly Up in Q1	04-24	MT
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending December 31, 2024; Provides Dividend Guidance for the Year Ending December 31, 2024	04-24	CI
Japan's Nikkei slips on caution ahead of US inflation data	04-09	RE
Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation	03-29	MT
Roche's Chugai Wins Japanese Approval for Piasky Injection	03-27	MT
Jefferies Adjusts Chugai’s Price Target to 7,000 Yen From 6,200 Yen, Keeps at Buy	03-04	MT
Interest Rates, Central Bank Outlooks Churn Asian Stock Markets	02-26	MT
Nikkei extends record rally on pharma boost	02-25	RE
Nikkei hits record high as index heavyweights advance	02-25	RE
US Tech Outlook Boost Asian Stock Markets	02-22	MT
Global markets live: Sanofi, ABB, Qualcomm, Roche, Shell...	02-01
Chugai Pharmaceutical’s Profit Down 13% in 2023	02-01	MT
Chugai Pharmaceutical Co., Ltd. Provides Consolidated Non-Audited Earnings Guidance for the Financial Year 2024	02-01	CI
From scandal to delisting: Toshiba's long-running crisis	12-19	RE
Jefferies Adjusts Chugai Pharmaceutical’s Price Target to 6,200 Yen From 5,400 Yen, Keeps at Buy	12-14	MT
Transcript : Chugai Pharmaceutical Co., Ltd. - Pre Recorded Special Call	11-27
Jefferies: Investor Interest Shifts from Daiichi Sankyo to Chugai and Otsuka Holdings	11-27	MT

Chart Chugai Pharmaceutical Co., Ltd

Duration

Period

More charts

Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).

Sector

Pharmaceuticals

Calendar

2024-07-25 - Q2 2024 Earnings Release

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Chugai Pharmaceutical Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

6,064 JPY

Average target price

5,946 JPY

Spread / Average Target

-1.94%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHUGAI PHARMACEUTICAL CO., LTD	+13.52%	65.5B
ELI LILLY AND COMPANY	+62.16%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.94%	359B
MERCK & CO., INC.	+15.78%	325B
ABBVIE INC.	+8.93%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+16.10%	177B
PFIZER, INC.	+2.17%	165B

Other Pharmaceuticals